Mineralys Therapeutics, Inc. MLYS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| -$154.65M+13.0% | -$177.81M-147% | -$71.9M-141% | ||
| $59K+37.2% | $43K— | $0— | ||
| $19.32M+70.5% | $11.34M+124% | $5.06M+1,012% | ||
| —— | —— | —— | ||
| -$2.47M— | —— | $9.53M+325% | ||
| $166K+139% | -$424K— | —— | ||
| -$142.42M+14.4% | -$166.31M-105% | -$81.17M-178% | ||
| $425M-13.0% | $488.5M+161% | $187.5M+275% | ||
| $814.74M+118% | $373.45M+7.3% | $347.97M+385% | ||
| -$389.75M-439% | $114.96M+170% | -$164.48M— | ||
| —— | $297K— | —— | ||
| $591M— | —— | $203.83M— | ||
| —— | —— | -$38.4M— | ||
| $9.88M+5.0% | $9.41M+37.0% | $6.87M+958% | ||
| $166K+139% | -$424K— | —— | ||
| -$2.47M— | —— | $9.53M+325% | ||
| $814.74M+118% | $373.45M+7.3% | $347.97M+385% | ||
| $391K-10.1% | $435K— | $0— | ||
| —— | $0— | —— | ||
| -$142.43M+14.4% | -$166.41M-105% | -$81.17M— | ||
| -$142.43M+14.4% | -$166.41M-105% | -$81.17M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Mineralys Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Mineralys Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.